Table 1 Demographic data from the different populations.

From: Study of vertebral fracture and Scanographic Bone Attenuation Coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls

 

RA

AS

Control

P

N = 105

N = 83

N = 56

Demographic characteristics

Age(mean(SD))

61.1 (9.5)

56.5 (10.76)*

65.2 (12.6)

0.0001

Women(N(%))

82 (78.1)

11 (13.3)*

49 (87.5)

0.0001

Smoking(N(%))

51 (48.6)

37 (44.6)

5 (8.9)**

0.0001

Disease duration(median(IQR))

12.0 (7: 20.5)

21 (9.5: 30)

/

0.002

Biological inflammation(N(%))

70 (66.7)

36 (43.4)

/

0.004

Corticosteroid therapy(N(%))

86 (81.9)

11 (13.25)

/

0.0001

BMI(median(IQR))

26.1 (22.6: 32.4)

25.4 (23.3: 30.9)

27.4 (23.1: 37.6)

0.384

Data on osteoporosis

Number of spine DXA(N(%))

104 (99)

29 (34.9)

/

0.0001

Osteoporosis on DXA (N (%))

28 (26.7)

5 (6.02)

/

0.22

Mean BMD on spine(mean(SD))

1.07 (0.2)

1.16 (0.24)

/

0.036

Clinical osteoporosis risk factor ≥2(N(%))

105 (100)

27 (32.5)

2 (3.6)

0.0001

Calcium and/or Vitamin D(N(%))

42 (40)

18 (21.68)

4 (7.1)

0.0001

Specific treatment(N(%))

37 (35.2)

13 (15.66)

0 (0)

0.002

  1. RA: Rheumatoid Arthritis, AS: Ankylosing spondylitis, DXA: Dual Energy X-ray Absorptiometry, BMI: Body Mass Index.
  2. Significant difference between RA and the other groups, p < 0.0001.
  3. Significant difference between RA and the other groups, p = 0.002.
  4. *Significant difference between AS and the other groups, p = 0.0001.
  5. **Significant difference between Control group and the other groups, p = 0.0001.